Correction: CMTM6 overexpression confers trastuzumab resistance in HER2‑positive breast cancer
- PMID: 38183152
- PMCID: PMC10768219
- DOI: 10.1186/s12943-023-01918-4
Correction: CMTM6 overexpression confers trastuzumab resistance in HER2‑positive breast cancer
Erratum for
-
CMTM6 overexpression confers trastuzumab resistance in HER2-positive breast cancer.Mol Cancer. 2023 Jan 10;22(1):6. doi: 10.1186/s12943-023-01716-y. Mol Cancer. 2023. PMID: 36627608 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
